Related Experiment Video

Updated: Feb 26, 2026

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment
11:13

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment

Published on: June 9, 2023

2.4K

Hydroxytyrosol Induces Apoptosis and Cell Cycle Arrest and Suppresses Multiple Oncogenic Signaling Pathways in

Haseeb Zubair1, Arun Bhardwaj1, Aamir Ahmad1

  • 1a Department of Oncologic Sciences , Mitchell Cancer Institute, University of South Alabama , Mobile , Alabama , USA.

Nutrition and Cancer
|July 19, 2017
PubMed
Abstract

Insights

Hydroxytyrosol (HT), a natural compound from olives, effectively inhibits prostate cancer cell growth and induces apoptosis. It shows cancer-specific effects, offering a promising therapeutic avenue for prostate cancer treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Natural Products Chemistry

Background:

  • Prostate cancer remains a significant health concern, with castration-resistant forms exhibiting complex signaling pathways.
  • Androgen receptor (AR) signaling, Akt, NF-κB, and STAT3 pathways are frequently activated in aggressive prostate cancers.
  • Hydroxytyrosol (HT), a polyphenol found in olives, has demonstrated potential as an anticancer agent.

Purpose of the Study:

  • To investigate the anticancer activity of hydroxytyrosol (HT) against prostate cancer cells.
  • To elucidate the underlying mechanisms of HT's action in prostate cancer.
  • To evaluate the specificity of HT's effects on cancer versus normal prostate cells.

Main Methods:

  • Prostate cancer cell lines (LNCaP, C4-2) and normal prostate epithelial cells (RWPE1, PWLE2) were treated with HT.
  • Cell proliferation, cell cycle progression, apoptosis, and key signaling pathway proteins (Akt, STAT3, NF-κB, AR) were analyzed.
  • Techniques included flow cytometry, Western blotting, and measurement of prostate-specific antigen secretion.

Main Results:

  • HT significantly inhibited proliferation in prostate cancer cells in a dose-dependent manner, sparing normal cells.
  • HT induced G1/S cell cycle arrest and apoptosis, evidenced by caspase activation and altered BAX/Bcl-2 ratio.
  • HT suppressed key oncogenic pathways by inhibiting Akt/STAT3 phosphorylation, inducing NF-κB cytoplasmic retention, and reducing AR expression and signaling.

Conclusions:

  • Hydroxytyrosol exhibits pleiotropic anticancer effects by targeting multiple oncogenic signaling pathways crucial in castration-resistant prostate cancer.
  • HT demonstrates cancer-cell-specific cytotoxicity, distinguishing it from treatments affecting normal cells.
  • These findings support further investigation of hydroxytyrosol as a potential therapeutic agent for prostate cancer.

More Related Videos

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen19:44

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen

Published on: May 30, 2012

19.2K

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.9K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.1K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.4K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
8.9K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
6.2K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.0K